GP120 INDEPENDENT INFECTION OF CD4(-) CELLS BY HIV-1
GP120 HIV-1 对 CD4(-) 细胞的独立感染
基本信息
- 批准号:6495224
- 负责人:
- 金额:$ 25.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS therapy HIV envelope protein gp120 HIV infections T lymphocyte cell line centrifugation confocal scanning microscopy enzyme linked immunosorbent assay flow cytometry fluorescence microscopy gel electrophoresis helper T lymphocyte human immunodeficiency virus 1 latent virus infection molecular cloning polymerase chain reaction subtraction hybridization virus infection mechanism virus integration virus protein virus replication
项目摘要
We have developed a new approach to sensitively and quantitatively identify HIV-1-infected cells, and found that HIV-1 significantly infects some types of CD4(-) cells independently of gp120. Further studies have indicated that not only can CD4(-) cells be infected by HIV-1 through this mechanism, but also CD4(+) T-lymphocytes. These results propose two very important possibilities: 1) HIV-1 can exploit some types of CD4(-) cells to serve as viral reservoirs in patients; and 2) HIV-1 can reduce expression of Env in infected cells as a strategy to evade the host immune response and therefore reside in these cells as long-term low-level persistent infection in a latent state. In this application, we will quantitatively characterize gp120- independent HIV-1 infection, and elucidate the molecular mechanism by which this occurs. In Specific Aim 1, CD4(-) cell lines derived from various human tissues will be infected with three strains of HIV-1 Env(-) virus. The susceptibility of CD4(-) cells to HIV-1 infection, the rates of viral replication in infected cells, the life-span of the infected cells, and the expression of viral genes in these cell lines will be studied. The results from Aim 1 studies will be informative to assess the seriousness of overall HIV-1 infection of CD4(-) cells in patients. In Specific Aim 2, we will study the mechanism of gp120-independent infection. We will characterize the infection course of HIV-1 gp120- independent infection, including viral entry, reverse transcription, nuclear transportation, viral DNA integration, and the generation of viral RNA genomes using an HIV-susceptible CD4(-) cell line, LNCaP, infected by HIV-1 Env(-) virus. We will also identify genes that are involved in gp120-independent HIV-1 infection using subtractive hybridization. The results from these studies will be very informative for assessing the seriousness of CD4(-) cell hosted HIV-1 reservoirs in patients and for developing an approach to interrupt the infection of CD4(-) cells by HIV-1.
我们开发了一种新的方法来敏感和定量地鉴定HIV-1感染细胞,并发现HIV-1独立于gp120显著感染某些类型的CD4(-)细胞。进一步的研究表明,不仅CD4(-)细胞可以通过这种机制被HIV-1感染,CD4(+) t淋巴细胞也可以通过这种机制被HIV-1感染。这些结果提出了两种非常重要的可能性:1)HIV-1可以利用某些类型的CD4(-)细胞作为患者体内的病毒库;2) HIV-1可以通过降低Env在感染细胞中的表达来逃避宿主免疫应答,从而以潜伏状态长期低水平持续感染这些细胞。在这个应用中,我们将定量表征不依赖gp120的HIV-1感染,并阐明其发生的分子机制。在特异性目标1中,来自各种人体组织的CD4(-)细胞系将被三株HIV-1 Env(-)病毒感染。将研究CD4(-)细胞对HIV-1感染的易感性、病毒在感染细胞中的复制率、感染细胞的寿命以及这些细胞系中病毒基因的表达。Aim 1研究的结果将为评估患者CD4(-)细胞总体HIV-1感染的严重程度提供信息。在Specific Aim 2中,我们将研究不依赖gp120的感染机制。我们将描述HIV-1 gp120非依赖性感染的感染过程,包括病毒进入、逆转录、核转运、病毒DNA整合,以及使用HIV-1 Env(-)病毒感染的hiv易感CD4(-)细胞系LNCaP生成病毒RNA基因组。我们还将使用减法杂交鉴定与gp120无关的HIV-1感染有关的基因。这些研究的结果将为评估患者体内CD4(-)细胞宿主HIV-1储存库的严重性以及开发一种阻断HIV-1感染CD4(-)细胞的方法提供非常有用的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shen Pang其他文献
Shen Pang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shen Pang', 18)}}的其他基金
A novel anti-scar peptide for cutaneous wound repair
一种用于皮肤伤口修复的新型抗疤痕肽
- 批准号:
8455289 - 财政年份:2013
- 资助金额:
$ 25.39万 - 项目类别:
A novel anti-scar peptide for cutaneous wound repair
一种用于皮肤伤口修复的新型抗疤痕肽
- 批准号:
8729393 - 财政年份:2013
- 资助金额:
$ 25.39万 - 项目类别:
GP120 INDEPENDENT INFECTION OF CD4(-) CELLS BY HIV-1
GP120 HIV-1 对 CD4(-) 细胞的独立感染
- 批准号:
6627771 - 财政年份:2002
- 资助金额:
$ 25.39万 - 项目类别:
GP120 INDEPENDENT INFECTION OF CD4(-) CELLS BY HIV-1
GP120 HIV-1 对 CD4(-) 细胞的独立感染
- 批准号:
6722820 - 财政年份:2002
- 资助金额:
$ 25.39万 - 项目类别:
TARGET SPECIFIC GENE THERAPY OF PROSTATE CANCER
前列腺癌的靶向特异性基因治疗
- 批准号:
2109239 - 财政年份:1995
- 资助金额:
$ 25.39万 - 项目类别:
TARGET SPECIFIC GENE THERAPY OF PROSTATE CANCER
前列腺癌的靶向特异性基因治疗
- 批准号:
2443130 - 财政年份:1995
- 资助金额:
$ 25.39万 - 项目类别:
TARGET SPECIFIC GENE THERAPY OF PROSTATE CANCER
前列腺癌的靶向特异性基因治疗
- 批准号:
2109238 - 财政年份:1995
- 资助金额:
$ 25.39万 - 项目类别:
TARGET SPECIFIC GENE THERAPY OF PROSTATE CANCER
前列腺癌的靶向特异性基因治疗
- 批准号:
2895221 - 财政年份:1995
- 资助金额:
$ 25.39万 - 项目类别:
TARGET SPECIFIC GENE THERAPY OF PROSTATE CANCER
前列腺癌的靶向特异性基因治疗
- 批准号:
2733121 - 财政年份:1995
- 资助金额:
$ 25.39万 - 项目类别:














{{item.name}}会员




